- £294.85m
- £55.56m
- $4.83m
- 50
- 60
- 39
- 46
REG - PureTech Health PLC - Half-year Report
AnnouncementRCS - PureTech Health PLC - PureTech Showcases Differentiated IPF Strategy
AnnouncementREG - PureTech Health PLC - Notice of Results
AnnouncementRCS - PureTech Health PLC - PRTC's Vedanta Announces VE202 Phase 2 Results
AnnouncementRCS - PureTech Health PLC - PRTC Launches Celea to Advance Ph3-Ready IPF Drug
AnnouncementREG - PureTech Health PLC - Holding(s) in Company
AnnouncementREG - PureTech Health PLC - Total Voting Rights
AnnouncementRCS - PureTech Health PLC - PRTC’s Seaport Begins Phase 2b Study in MDD
AnnouncementREG - PureTech Health PLC - PureTech Announces Leadership Transition
AnnouncementREG - PureTech Health PLC - Directorate Change
AnnouncementREG - PureTech Health PLC - PDMR Notification RSU Vesting
AnnouncementREG - PureTech Health PLC - PDMR Notification RSU Vesting
AnnouncementREG - PureTech Health PLC - PDMR Notification
AnnouncementREG - PureTech Health PLC - Total Voting Rights
AnnouncementRCS - PureTech Health PLC - PRTC'S Vor Announces RemeGen License & $175M PIPE
AnnouncementREG - PureTech Health PLC - Result of AGM
AnnouncementREG - PureTech Health PLC Citigroup Inc - Holding(s) in Company
AnnouncementRCS - PureTech Health PLC - PRTC to Present at Jefferies Healthcare Conference
AnnouncementRCS - PureTech Health PLC - PRTC: IPF Data Support Lung Function Stabilization
Announcement